Midazolam Injection, Solution
Product Images NDC 76045-001

19 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 76045-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mid08 0005 01

Mid08 0005 01
Chemical structure diagram of Midazolam Hydrochloride, displaying its core fused ring system with chlorine and fluorine substituents as depicted in the image.*
FDA Label Image

Mid08 0005 02

Mid08 0005 02
Chemical structure diagram displaying the molecular forms of Midazolam and its open-ring form. The image shows the structural difference between the closed-ring Midazolam molecule and the open-ring variant, illustrating their chemical relationship.*
FDA Label Image

Mid08 0005 03

Mid08 0005 03
A line graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of open-ring form on the y-axis against pH values on the x-axis, demonstrating a decreasing trend as pH increases from 2.5 to 5.5.*
FDA Label Image

Mid08 0005 04

Mid08 0005 04
An instructional diagram showing the components of a prefilled syringe assembly for injection. The labeled parts include the outer package, plunger rod, label (with a note not to remove), syringe barrel, luer lock collar (with a note not to remove), and syringe tip cap.*
FDA Label Image

Mid08 0005 05

Mid08 0005 05
An instructional illustration depicting hands peeling open a blister pack containing a prefilled syringe, likely demonstrating how to access the midazolam injection.*
FDA Label Image

Mid08 0005 06

Mid08 0005 06
An instructional black-and-white line drawing showing hands demonstrating the process of connecting or preparing a syringe with a capped needle or vial. The image indicates twisting or attaching with an arrow for direction, likely illustrating a step in using an injection device, consistent with use instructions for an injectable drug.*
FDA Label Image

Mid08 0005 07

FDA Label Image

Mid08 0005 08

Mid08 0005 08
Packaging label for Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) preservative-free solution by Fresenius Kabi USA. The carton is for 24 single-dose prefilled syringes of 2 mL each, intended for intravenous or intramuscular use only. The label includes NDC 76045-211-20 and usage warnings not to place the syringe on a sterile field.*
FDA Label Image

Mid08 0005 09

Mid08 0005 09
Midazolam Injection USP 2 mg/2 mL (1 mg/mL) in a 2 mL single-dose prefilled syringe label. It is preservative free and intended for intravenous or intramuscular use only. The label includes storage instructions, dosage reference to the package insert, and handling warnings. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Mid08 0005 10

Mid08 0005 10
Label for Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) preservative free solution. The label indicates a 2 mL single-dose vial for intravenous or intramuscular use only, marked with dosing scale in mL. It is labeled by Fresenius Kabi and includes a barcode and control number.*
FDA Label Image

Mid08 0005 11

Mid08 0005 11
Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) preservative-free solution for intravenous or intramuscular use. The packaging contains 24 single-dose 2 mL prefilled syringes. The labeler is Fresenius Kabi USA, LLC. The box features orange panels with black text and includes usage warnings and product identification on multiple sides.*
FDA Label Image

Mid08 0005 12

Mid08 0005 12
Label for Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) solution in a 2 mL single-dose prefilled syringe. The label states it is preservative free and for intravenous or intramuscular use only. It includes storage instructions, usage notes, and is labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Mid08 0005 13

Mid08 0005 13
Midazolam Injection, USP label for a 2 mL single-dose vial, strength 2 mg/2 mL (1 mg/mL), preservative free. The label indicates use for intravenous or intramuscular administration and includes a volume scale from 0.5 mL to 2 mL. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Mid08 0005 14

Mid08 0005 14
Packaging label for Midazolam Injection, USP 5 mg/mL, preservative-free solution for intravenous or intramuscular use. The label indicates 24 single-dose prefilled syringes of 1 mL each. The product is labeled by Fresenius Kabi USA, LLC and includes instructions to not place the syringe on a sterile field and to discard unused portions. NDC 76045-002-10 is visible on the label.*
FDA Label Image

Mid08 0005 15

Mid08 0005 15
Label for Midazolam Injection, USP 5 mg/mL preservative-free solution in a 1 mL single-dose prefilled syringe. Indicated for intravenous or intramuscular use only. The label includes storage instructions (20° to 25°C), usage warnings, barcode, lot number, and expiration date fields. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Mid08 0005 16

Mid08 0005 16
Label for Midazolam Injection, USP, 5 mg/mL preservative-free solution. The label notes it is a 1 mL single-dose vial for intravenous or intramuscular use only. It includes dosage markings up to 1 mL and the Fresenius Kabi logo. A barcode and NDC number are also visible.*
FDA Label Image

Mid08 0005 17

Mid08 0005 17
Packaging label for Midazolam Injection, USP 10 mg/2 mL (5 mg/mL) preservative-free solution. The label indicates the product is for intravenous or intramuscular use only and contains 24 single-dose prefilled syringes of 2 mL each. The labeler is Fresenius Kabi USA, LLC. The layout includes product name, strength, usage instructions, and handling warnings.*
FDA Label Image

Mid08 0005 18

Mid08 0005 18
Label of Midazolam Injection, USP 10 mg/2 mL (5 mg/mL) in a 2 mL single-dose prefilled syringe. The label states it is preservative free and intended for intravenous or intramuscular use only. It includes storage instructions at 20° to 25°C and advises protection from light. The product is labeled by Fresenius Kabi USA, LLC with placeholder text for expiration date and lot number.*
FDA Label Image

Mid08 0005 19

Mid08 0005 19
Label for Midazolam Injection, USP, preservative free, with a strength of 10 mg/2 mL (5 mg/mL). The label indicates a 2 mL single-dose vial for intravenous or intramuscular use only. The labeler is Fresenius Kabi USA, LLC. The label includes a volume scale and a barcode under the text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.